NSC 74859

NSC 74859

Catalog Number:
L002369482APE
Mfr. No.:
APE-A8338
Price:
$188
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          S3I-201 is a selective inhibitor of Stat3 with IC50 value of 86 μM [1].
          In the in vitro Stat3 DNA-binding assay, S3I-201 showed potent inhibition of the Stat3 DNA-binding activity with an average IC50 of 86 μM. In the EMSA assay, S3I-201 selectively inhibited Stat3 DNA-binding activity over that of Stat1 and Stat5. It suppressed the complex formation of Stat1-Stat3 and Stat1-Stat1 with IC50 values of 160 and > 300 μM, respectively. Besides that, the unphosphorylated, inactive Stat3 monomer was found to restore the Stat3 DNA-binding activity inhibited by S3I-201, suggesting that the inhibition was independent on the activation status. In NIH 3T3/v-Src fibroblasts, S3I-201 inhibited the constitutive activation of Stat3 and reduced the pTyr-705 Stat3 levels. Moreover, S3I-201 was found to significantly induce apoptosis in cells with constitutively active Stat3 at concentration of 30–100 μM. S3I-201 also reduced the expression of cyclin D1, Bcl-xL and surviving in these cells [1].

          [1] Siddiquee K, Zhang S, Guida W C, et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proceedings of the National Academy of Sciences, 2007, 104(18): 7391-7396.

      • Properties
        • Alternative Name
          S3I-201;NSC74859;NSC-74859;S3I 201; 2-hydroxy-4-[[2-(4-methylphenyl)sulfonyloxyacetyl]amino]benzoic acid
          CAS Number
          501919-59-1
          Molecular Formula
          C16H15NO7S
          Molecular Weight
          365.36
          Purity
          98.39%
          Solubility
          insoluble in H2O; ≥18.25 mg/mL in DMSO; ≥2.2 mg/mL in EtOH with gentle warming
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Qi Yuan, Jianchun Gu, et al. "MyD88 in myofibroblasts enhances colitis-associated tumorigenesis via promoting macrophage M2 polarization." Cell Rep. 2021 Feb 2;34(5):108724. PMID:33535045
          2. Deng R, Zhang P, et al. "HDAC is indispensable for IFN-γ-induced B7-H1 expression in gastric cancer." Clin Epigenetics. 2018 Dec 11;10(1):153. PMID:30537988
          3. Xu J, Li Y, et al. "Baicalin regulates SirT1/STAT3 pathway and restrains excessive hepatic glucose production."Pharmacol Res. 2018 Aug 23;136:62-73. PMID:30144531
          4. Yang L, Xu J, et al. "Porcine epidemic diarrhea virus-induced epidermal growth factor receptor activation impairs the antiviral activity of type I interferon." J Virol. 2018 Jan 31. pii: JVI.02095-17. PMID:29386292
          5. Zhang ZL, Jiang QC, et al. "Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation." Breast Cancer. 2017 Nov 27. PMID:29181822
          6. Marie R.Mooney."Precision Medicine Approaches to Integrating Genomics with Cancer Therapy: Applications in Glioblastoma and Lymphoma." ProQuest LLC. 2016.

    We Also Recommend

    Go 6976

    $320

    TAK-875

    $306

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.